JoVE Logo

Iniciar sesión

3.18 : Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be formed. Glucuronidation occurs at the luminal side of the endoplasmic reticulum. This process requires an activated endogenous cofactor, which transfers glucuronic acid to the substrate's reactive functional group. The enzyme responsible for facilitating this transfer is UDP-glucuronyl transferase. The resulting metabolites have high molecular weights and are typically excreted through bile. Sulfation, on the other hand, takes place within the cytosol of the cell. This reaction involves the formation of an active endogenous cofactor called phosphoadenosyl phosphosulfate (PAPS). PAPS transfers a sulfate group to the substrate's reactive site in the presence of the sulfotransferase enzyme.

Tags

Drug MetabolismPhase II ReactionsDetoxificationConjugationHydrophilic Drug ConjugatesSulfationGlucuronidationBiologically Inactive MetabolitesProdrugsUDP glucuronyl TransferaseBile ExcretionPhosphoadenosyl Phosphosulfate PAPSSulfotransferase Enzyme

Del capítulo 3:

article

Now Playing

3.18 : Drug Metabolism: Phase II Reactions

Pharmacokinetics

3.6K Vistas

article

3.1 : Farmacocinética: Introducción

Pharmacokinetics

5.4K Vistas

article

3.2 : Mecanismo de absorción de fármacos: transporte pasivo de membrana

Pharmacokinetics

3.6K Vistas

article

3.3 : Mecanismo de absorción de fármacos: transporte de membrana mediado por portadores

Pharmacokinetics

3.5K Vistas

article

3.4 : Absorción de fármacos: factores que afectan a la absorción gastrointestinal

Pharmacokinetics

3.8K Vistas

article

3.5 : Biodisponibilidad: Visión general

Pharmacokinetics

2.7K Vistas

article

3.6 : Factores que influyen en la biodisponibilidad: eliminación en el primer paso

Pharmacokinetics

6.1K Vistas

article

3.7 : Bioequivalencia: Visión general

Pharmacokinetics

915 Vistas

article

3.8 : Efecto de primer paso

Pharmacokinetics

5.0K Vistas

article

3.9 : Curso temporal del efecto de la droga

Pharmacokinetics

1.9K Vistas

article

3.10 : Distribución de fármacos: unión de tejidos

Pharmacokinetics

2.5K Vistas

article

3.11 : Barreras fisiológicas

Pharmacokinetics

3.4K Vistas

article

3.12 : Distribución de fármacos: unión a proteínas plasmáticas

Pharmacokinetics

4.8K Vistas

article

3.13 : Modelos de compartimentos: Modelo de un solo compartimento

Pharmacokinetics

2.1K Vistas

article

3.14 : Modelos de compartimentos: modelo de dos compartimentos

Pharmacokinetics

5.2K Vistas

See More

JoVE Logo

Privacidad

Condiciones de uso

Políticas

Investigación

Educación

ACERCA DE JoVE

Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados